Same-day colectomy safety for selected patients undergoing robotic colorectal surgery.
Official title: Same-Day Colectomy: is it Safe for Patients?
Run by University of Arizona · NCT07176715 · Data updated 2026-11-12
This project tests whether adults having robotic-assisted right colectomy, sigmoidectomy, or low anterior resection can safely go home the same day after surgery.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 70 Years |
| Sex | All |
| Enrollment | 150 (estimated) |
| Sponsor | University of Arizona Academic / other |
| Locations | 1 site (Phoenix, Arizona) |
| Status | Recruiting |
| Started | September 25, 2025 |
| Main results expected | September 1, 2029 |
| Study ends | September 1, 2030 |
| Registry record updated | July 23, 2026 |
| Trial ID | NCT07176715 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18–70 undergoing robotic-assisted right colectomy, sigmoidectomy, or low anterior resection with >4 METS functional capacity, controlled hypertension or diabetes as specified, a designated adult caregiver, and access to a phone or computer are ideal candidates.
✕Probably not a fit
Patients with poor functional status, uncontrolled medical problems, ongoing antiplatelet therapy that cannot be paused, lack of a home caregiver, or inability to access follow-up resources are unlikely to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective cohort at a single academic center following patients selected for outpatient robotic-assisted colorectal operations to record early postoperative outcomes. Eligible patients are adults with good functional capacity and controlled chronic conditions who have a responsible caregiver and access to phone/computer at home. Perioperative requirements include stopping certain antiplatelet drugs before surgery, completion of pre/postoperative education, and same-day discharge with planned clinic follow-up. The study tracks complications, emergency visits, readmissions, and recovery measures to determine whether same-day colectomy is a viable option for a select group of patients.
Why it matters
Potential benefit: If successful, selected patients could recover at home sooner with shorter hospital stays, potentially lowering costs and exposure to inpatient risks.
How similar studies have gone: Single-center reports and enhanced recovery programs have shown outpatient colectomy can be feasible and safe in carefully selected patients, but larger randomized data are limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Ages 18-70 * Undergoing robotic-assisted right colectomy, sigmoidectomy, or low anterior resection. * Able to perform greater than 4 metabolic equivalents (METS) without shortness of breath * Must have a designated adult who can care for them at home postoperatively until their in-person clinic visit * Access to a cell phone or computer and running water. * Successfully completed pre-operative and post-operative education * Medical criteria: * Well controlled hypertension with systolic blood pressure \< 140 controlled by less than two medications which they are compliant with * Well controlled diabetes on oral agents only with blood glucose level \< 180 on daily checks * Anti-platelet agents including aspirin, clopidogrel, prasugrel, ticagrelor or ticlopidine will be stopped 7 days preoperatively and restarted on postoperative day 1. See exclusion criteria 7 for specific exclusion criteria regarding antiplatelet agents. Exclusion Criteria: * Medical criteria: * Neurocognitive deficits not allowing for adequate preoperative education * Congestive heart failure with EF \< 45% * Symptomatic aortic stenosis causing heart failure, syncope, dyspnea or angina * Pulmonary fibrosis or pulmonary hypertension * COPD or home oxygen use \> 2L * Chronic kidney disease of any stage. * Lack of a caregiver at home or functionally bed-bound * Ultralow pelvic resection * Need for ostomy creation intraoperatively * Operative time greater than 5 hours as this likely indicates a complex case and dissection necessitating closer monitoring in the hospital * Conversion to open procedure intraoperatively * Patients receiving antiplatelet agents such as clopidogrel, prasugrel, ticagrelor or ticlopidine within one year of coronary or carotid stent implantation, TAVR or LAAO placement. * Patients on therapeutic anticoagulation medications such as warfarin, Eliquis, Xarelto, Enoxaparin * Current tobacco use * Patients who were unable to complete preoperative education, do not feel comfortable with care at home, or do not have an available caregiver for the first 7 postoperative days * Any surgical history that would preclude safe abdominal entry for robotic surgery
Where it's running
-
Banner University Medical Center Phoenix
Phoenix, Arizona, United States Recruiting
Study contacts
- Principal investigator: Eugene Kim, MD — University of Arizona
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Pain management plan implementation for major open abdominal surgeries
This trial tests an opioid-epidural pain management approach to see if it improves post-surgical pain control for adults undergoing open abdominal procedures like colectomy, hepatectomy, and nephrectomy.
-
Regular Diet After Colon Surgery
This pilot test will see if going back to a normal, non-restricted diet after colorectal surgery is safe and feasible for adults.
-
Creating a temporary bowel connection with the GT Metabolic magnet system.
This trial will test if the GT Metabolic Magnet System can safely create temporary bowel connections for people needing colorectal or ileocolic anastomoses.
-
Perioperative IV nimodipine for people undergoing open colectomy for bowel cancer
This trial tests whether giving intravenous nimodipine around the time of open colectomy can reduce opioid use, lower pain, and speed early bowel recovery for people having surgery for bowel cancer.
-
Using blood tests to personalize chemotherapy for colorectal and appendiceal cancer patients
This study is testing if blood tests that check for tumor DNA can help doctors personalize chemotherapy for patients with colorectal or appendiceal cancer to improve their chances of staying cancer-free after surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.